Skip to main content
Figure 3 | Genetic Vaccines and Therapy

Figure 3

From: Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cells

Figure 3

In vivo tumor formation by HepG2 (A), L9981 (B) and NL9980 (C) cells. HepG2, L9981 and NL9980 cells with different pre-treatments were implanted subcutaneously into nude mice. Ten days after implantation, the mice were treated with 5-Fc and GCV for another 20 days. The mice were sacrificed and the tumors were removed intact and weighed. There were no significant difference in tumor weights among different treatment of HepG2 group, but L9981 and NL9980 groups with CD and TK transgene showed significantly smaller tumors than the other two groups.

Back to article page

Genetic Vaccines and Therapy

ISSN: 1479-0556